Therapy Areas: Diabetes
Qatar- WCM-Q enters into ties with US firm
26 August 2019 -

Doha-based Weill Cornell Medicine-Qatar (WCM-Q) has said that it has signed a research agreement with US-based biotechnology company, Moderna, it was reported on Monday.

The two firms are to work together to develop a new drug for controlling cholesterol. The firms are hoping that the new drug would improve treatments for type 2 diabetes and cardiovascular disease.

The agreement would see Moderna sponsor a study by WCM-Q researcher, Dr Hani Najafi.

Since its launch in 2010, Moderna has developed a technology platform for developing mRNA-based therapies.

Login
Username:

Password: